Investing

7 IPOs for Week of June 8 Include 2 Biotechs

IPO
Source: Thinkstock
At the end of last week, all four of the companies on the initial public offering (IPO) calendar were trading publicly. Judged on the basis of their first-day pop, DAVIDsTEA Inc. (NASDAQ: DTEA) was the week’s big winner, closing up 42% at $27.00. The Ottawa, Canada, company priced its shares at $19, above the expected range, and the day just got better for it after that.

EndoChoice Holdings Inc. (NYSE: GI) price at $15, the low end of its expected range, but popped 13% to close at $17. PennTex Midstream Partners L.P. (NASDAQ: PTXP) priced at $20, the midpoint of the expected range, but closed down 2% at $19.55. Evolvent Health Inc. (NYSE: EVH) priced at $17 a share, a buck higher than the expected range, and the shares closed up 11% at $18.86 after Friday’s IPO.

IPO ETF manager Renaissance Capital reported that 73 IPOs have priced in the United States so far this year, down nearly 38% from a year ago. Total proceeds raised through June 5 equaled $12.9 billion, down about 46% compared with the same period in 2014. Of the 73 IPOs that have gone off this year, 32 have come from the health care sector. Last year’s IPO total came in at $85.2 billion, the highest total in the past 10 years. Renaissance Capital does not include “best efforts” or blank check companies in its totals.

There are seven IPOs on next week’s calendar, including three health care companies, a bank holding company, a solar investment firm, a Chinese brick-maker and a restaurant chain specializing in chicken wings.

People’s Utah Bancorp is a bank holding company with 18 retail banking branches. The company plans to offer 2.5 million shares in an expected price range of $13 to $15 to raise $35 million at a market cap of around $239 million. Sole bookrunner for the deal is D.A. Davidson. Co-managers are Sandler O’Neill and FIG Partners. The IPO is currently scheduled to price and to begin trading in the week of June 8 on the Nasdaq under the ticker symbol PUB.
Yulong Eco-Materials Ltd. is making another attempt at entering the public market. The China-based company makes fly-ash bricks and concrete for China’s construction industry. The firm plans to sell 2.3 million shares in an expected price range of $6.25 to $7.25, raising $15.2 million at a market cap of around $79 million. Joint bookrunners for the offering are Axiom Capital Management, Northland Securities and ViewTrade Securities. The shares are currently scheduled to price and begin trading in the week of June 8 on the Nasdaq under the ticker symbol YECO.

Axovant Sciences Ltd. is a clinical-stage biopharmaceutical company developing and commercializing novel therapeutics for the treatment of neurodegenerative disorders such as dementia. The company plans to offer 17.9 million shares in an expected price range of $13 to $15, raising about $251 million at a market cap of $1.3 billion. Joint bookrunners for the offering are Jefferies, Evercore Partners and RBC Capital Markets. Co-managers are JMP Securities and Baird. The shares are currently scheduled to price on Wednesday and begin trading Thursday on the New York Stock Exchange under the ticker symbol AXON.

Invuity Inc. is a medical device company using advanced photonics to provide surgeons with improved direct visualization of surgical cavities during minimally invasive and minimal access surgical procedures. The company plans to offer 4 million shares in an expected price range of $14 to $16 to raise $60 million at a market cap of around $189 million. Joint bookrunners for the deal are Piper Jaffray, Leerink Partners and Stifel. William Blair is the sole co-manager. The shares are currently scheduled to price on Wednesday and begin trading Thursday on the Nasdaq under the ticker symbol IVTY.

Biotie Therapies OYJ is a Finland-based biopharmaceutical company primarily focused on developing therapeutics for central nervous system disorders. The company, which currently trades on the Finnish stock exchange, plans to offer 3.4 million shares at an IPO price of $14.82. Joint bookrunners for the offering are RBC Capital Markets and Stifel. Co-managers are JMP Securities and Roth Capital. The shares are currently scheduled to price on Thursday and begin trading Friday on the Nasdaq under the ticker symbol BITI.

Principal Solar Inc. plans to acquire, build, own and operate profitable, large-scale solar generation facilities, while also creating a website that is a focal point for solar vendors and buyers, and to create an innovative solar company. The company plans to offer 2.5 million shares in an expected price range of $9 to $11, raising $25 million at a market cap of $56 million. The company already trades on the OTC Pink under the symbol PSWW. Sole underwriter for the offering is Northland Securities. The shares are currently scheduled to price on Thursday and begin trading Friday on the Nasdaq under the ticker symbol PSWW.

Wingstop Inc. is a franchisor and operator of restaurants that specialize in cooked-to-order, hand-sauced and tossed chicken wings. The company plans to offer 5.8 million shares in an expected price range of $12 to $14, raising around $75 million at a market cap of about $372 million. Joint bookrunners for the offering are Morgan Stanley, Jefferies, Baird, Goldman Sachs, Barclays and Wells Fargo Securities. The shares are currently scheduled to price on Thursday and begin trading Friday on the Nasdaq under the ticker symbol WING.

ALSO READ: The States With the Most People Dying From Cancer

Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)

Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.

Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.

Click here now to get started.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.